Form 4 for BIVI BIOVIE INC.
Accepted 2023-06-26 00:00:00 ET · period of report 2023-06-21 · accession 0001520138-23-000269 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-06-26 | 2023-06-21 | BIVI | DO CUONG V | CEO, Pres, Dir | M - OptEx | — | +41.5K | 271.4K | +18% | — |
| DI | 2023-06-26 | 2023-06-21 | BIVI | DO CUONG V | CEO, Pres, Dir | M - OptEx | $0.00 | -41.5K | 83.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-21 | M | A | 41,506 | — | 271,401 | I See Footnote | — | — | (F1) Granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan. (F2) Securities are held in the name of Do & Rickles Investments LLC. |
| 2 | Derivative | Restricted stock units | 2023-06-21 | M | D | 41,506 | $0.00 | 83,014 | I See Footnote | — · — to — | 41,506 Common Stock | (F1) Granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan. (F2) Securities are held in the name of Do & Rickles Investments LLC. (F3) Each restricted stock unit represents a contingent right to receive one share of the issuer's Class A common stock. (F4) The restricted stock units were granted on June 21, 2022 and vest ratably over a three-year period on each anniversary of the grant date. |